Known, a company developing accountability infrastructure for autonomous AI, announced that Edna Conway, former senior security executive at Microsoft and Cisco, has joined its Advisory Council. Conway brings extensive experience in cybersecurity and risk management, enhancing Known's efforts to create open, interoperable accountability systems for AI agents operating across organizations and platforms. She will support the advancement of DNSid, a DNS-based system that links AI agents to responsible organizations, addressing the critical need for trust and accountability in AI autonomy. This move strengthens Known's position in building trusted AI ecosystems globally.
The news about Edna Conway joining Known's Advisory Council is presented here with Technology-sector market data from Pluang as of Nov 02, 2026 19:21 WIB. For readers following Technology stocks, 96 of 150 priced US stocks rose and 40 fell today on Pluang. Notable movers include CRWD at USD 258.78 with a 3.35% increase and APP at USD 236.12 with a 3.34% increase, while ASAN declined by 3.43% to USD 10.83.
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
Radiopharm Theranostics announced progress in its oncology radiopharmaceutical pipeline, including preparing for a pivotal Phase 3 imaging trial of RAD101 for recurrent brain metastases after a successful FDA End-of-Phase 2 meeting. The company also ...
UroGen Pharma has dosed the first patient in a Phase 1 trial testing UGN-501, a next-generation oncolytic virus for non-muscle invasive bladder cancer (NMIBC). The trial aims to evaluate the safety and tolerability of UGN-501 administered directly in...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
